Angiotensin converting enzyme (ACE) inhibitors are a class of drugs that can effectively reduce the systemic vascular resistance of patients with chronic kidney disease, thereby achieving long-term renal protection (162). The gene discussed is ACE; the disease is chronic kidney disease.